Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy, including Merck & Co. The US regulator cleared BMS' LAG-3 drug relatlimab ...

See [demo] [code] [ckpt]! [2024.04.18] - 👏👏👏The training code ... The former uses inputs like text glyph, position, and masked image to generate latent features for text generation or editing. The ...

Each chunk (24 frames) is denoised holistically, and the generation of the next chunk begins as soon as the current one reaches a certain level of denoising. This pipeline design enables concurrent ...